T-Up/Astec Biologics criminal charges
This article was originally published in The Tan Sheet
Executive Summary
Firms' President Allen Hoffman sentenced Nov. 30 to 46 months in federal prison, ordered to pay $222,506 restitution after pleading guilty to two counts of introducing unapproved new drug (aloe vera compounds) into interstate commerce with intent to defraud. A Baltimore federal jury had deadlocked on all but one charge against Hoffman and T-Up in a June 2000 trial (1"The Tan Sheet" July 3, 2000, In Brief). Hoffman marketed products as treatments for cancer, other diseases...
You may also be interested in...
T-Up, Inc.
Baltimore firm and its principals are appealing a $3.7 mil. fine by the Maryland Attorney General for making claims their aloe vera and mineral health products cure diseases such as cancer and AIDS. T-Up products were marketed for oral consumption or IV administration without FDA approval and lacked adequate safety and efficacy data, the AG asserted. T-Up, President Allen Hoffman and two others were indicted in July 1999 on federal charges of conspiracy, mail and wire fraud and introducing an unapproved new drug into commerce. A Baltimore federal jury on June 15 deadlocked on all but one charge against the firm and Hoffman, finding them not guilty on one mail fraud count. The jury found an Oklahoma supplier of the products not guilty on all counts
California Court’s Inaction On TiO2 Prop 65 First Amendment Case Breeds New Lawsuits
The Personal Care Products Council seeks to stem the rising tide of titanium dioxide Proposition 65 lawsuits, requesting that a California court prohibit the state’s Attorney General and private enforcers from filing and/or prosecuting new suits against cosmetics companies failing to warn about potential TiO2 exposure.
Kenvue Breaks Ground On New Headquarters, Appoints Chief Corporate Affairs Officer
Firm hosts groundbreaking for 290,000 square-foot global headquarters it’s having built in Summit, NJ, starting with 100,000 square-foot science and innovation and expected to open in 2025. It announced adding Russell Dyer as chief corporate affairs officer starting 13 March.